RAS (KRAS OR NRAS) GENE MUTATION
Clinical trials for RAS (KRAS OR NRAS) GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAS (KRAS OR NRAS) GENE MUTATION trials appear
Sign up with your email to follow new studies for RAS (KRAS OR NRAS) GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets hard-to-treat cancers with MAPK mutations
Disease control Recruiting nowThis early-stage study tests an experimental oral drug, NST-628, in adults with advanced solid tumors that have specific genetic changes in the MAPK pathway. The main goals are to check the drug's safety, find the right dose, and see if it shrinks tumors. About 230 participants w…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Massive canadian study hunts rare cancer clues
Knowledge-focused Recruiting nowThis study follows 5,500 Canadian cancer patients whose tumors have rare genetic changes. Researchers will collect data on how these cancers behave and how well different treatments work, including newer targeted drugs. The goal is to learn more about these uncommon mutations to …
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC